Cargando…
Deprescribing: A Prime Opportunity to Optimize Care of Cancer Patients
Patients with incurable cancers have an increasing number of comorbidities, which can lead to polypharmacy and its associated adverse events (drug-to-drug interaction, prescription of a potentially inappropriate medication, adverse drug event). Deprescribing is a patient-centered process aimed at op...
Autores principales: | Chaput, Genevieve, Bhanabhai, Hitesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670366/ https://www.ncbi.nlm.nih.gov/pubmed/37999124 http://dx.doi.org/10.3390/curroncol30110704 |
Ejemplares similares
-
Implementation of pharmacist-led deprescribing in collaborative primary care settings
por: Trenaman, Shanna C., et al.
Publicado: (2022) -
Understanding Global Deprescribing Policy: Opportunities and Challenges
por: Kim, Catherine, et al.
Publicado: (2021) -
Deprescribing in Palliative Cancer Care
por: Hedman, Christel, et al.
Publicado: (2022) -
Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe
por: Shrestha, Shakti, et al.
Publicado: (2021) -
Deprescribing as an Opportunity to Facilitate Patient-Centered Care: A Qualitative Study of General Practitioners and Pharmacists in Japan
por: Ie, Kenya, et al.
Publicado: (2023)